To include your compound in the COVID-19 Resource Center, submit it here.

Lysosomal ceramidase ASAH1 identified as Krabbe disease target

DISEASE CATEGORY: Neurology

INDICATION: Leukodystrophy

A team from BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) and Washington University

Read the full 133 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE